PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31975555-6	2020	High-level hepatic MsrA significantly reduced the plasma free cholesterol contents, improved HDL functional proteins apolipoprotein A-I (apoAI), apoE, paraoxonase1 (PON1), and lecithin:cholesterol acyltransferase (LCAT), while decreased the pro-inflammatory property of dysfunctional HDL, contributing to reduced atherosclerosis and hepatic steatosis in Western diet-fed mice.	Cholesterol	62-73	methionine sulfoxide reductase A	Mus musculus	19-23	
9069289-1	1997	Macrophage type-I and type-II class-A scavenger receptors (MSR-A) are implicated in the pathological deposition of cholesterol during atherogenesis as a result of receptor-mediated uptake of modified low-density lipoproteins (mLDL).	Cholesterol	115-126	methionine sulfoxide reductase A	Mus musculus	59-64	
31975555-7	2020	Furthermore, the study revealed that hepatic MsrA altered the expression of several genes controlling HDL biogenesis, cholesterol esterification, cholesterol uptake mediated by low-density lipoprotein receptor (LDLR) and biliary excretion, as well as suppressed nuclear factor kappaB (NF-kappaB) signaling pathway, which largely relied on liver X receptor alpha (LXRalpha)-upregulation.	Cholesterol	118-129	methionine sulfoxide reductase A	Mus musculus	45-49	
31975555-7	2020	Furthermore, the study revealed that hepatic MsrA altered the expression of several genes controlling HDL biogenesis, cholesterol esterification, cholesterol uptake mediated by low-density lipoprotein receptor (LDLR) and biliary excretion, as well as suppressed nuclear factor kappaB (NF-kappaB) signaling pathway, which largely relied on liver X receptor alpha (LXRalpha)-upregulation.	Cholesterol	146-157	methionine sulfoxide reductase A	Mus musculus	45-49